Click the link https://www.teknoscienze.com/Contents/Riviste/Sfogliatore/CO5_2022/8/ to read the latest interview with our CEO Dr Aslam Malik in the October issue of ChemistryToday
SK pharmteco, the world leaders in continuous flow processing is a hosting a symposium for customers and key contacts entitled ‘Continuous Process Applications in the Pharmaceutical Industry’ due to be held on Thursday 13th October at the Le Meridien Hotel, Cambridge, MA. Click the link to view the updated line-up of speakers from Massachusetts Institute
SK pharmteco Continuous Flow Symposium Read More »
In this latest issue of tks | publisher, event organiser, media agency #ChemistryToday read an interview with one of our #ContinuousFlow SMEs Dr Olivier Dapremont, Executive Director Process Technologies AMPAC Fine Chemicals an SK pharmteco Company. #SKpharmteco is a world-leader in #ContinousFlowProcessing, Olivier shares his expertise as he talks about #SMB and #batchchromatography sharing many
ChemistryToday Interview with Continuous Flow SME Dr Olivier Dapremont Read More »
AMPAC Fine Chemicals, an SK Pharmteco company, adds additional pharmaceutical development and engineering capabilities with the opening of a new Complex Molecule Chemistry & Engineering Center Rancho Cordova, California, August 24, 2022 AMPAC Fine Chemicals (AFC), an SK pharmteco Company, a leading manufacturer of Active Pharmaceutical Ingredients in the United States, expanded its pharmaceutical manufacturing capabilities
AMPAC Fine Chemicals Announces Expansion of Capabilities in California Read More »
https://www.independent.ie/business/irish/korean-pharma-group-sk-pharmteco-anticipates-growth-and-raises-spending-on-dublin-site-expansion-41844647.html
Safety First, Quality Always isn’t just a tag line for SK pharmteco and its business units; learn about our High Potency API manufacturing capabilities and robust safety controls both at AMPAC Fine Chemicals an SK pharmteco Company and at our sister site SK biotek Ireland an SK pharmteco Company with an article written by SK
SK pharmteco’s HPAPI Robust Safety Controls Article in Specialty Chemicals Magazine Read More »
SK pharmteco to invest extra $30m for Irish plant expansion, in total $65 million allocated for expansion of SK biotek Ireland’s Dublin-based pharma manufacturing plant.
The Korean Herald: SK pharmteco to invest extra $30m for Irish plant expansion Read More »
SK pharmteco announces $35m investment in Phase 1 of new expansion plan for SK biotek Ireland’s Swords Campus SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant. This project will provide a
In February’s issue ChemistryToday Brian Mullan Yposkesi’s Head of Development & Innovation has published an article on how C> are a fast growing and promising class of medicines, that offer the possibility of curing conditions with a genetic basis, that have few or no other options for patients. Click here to read Brian’s article: https://www.teknoscienze.com/wp-content/uploads/2022/02/Mullan_CO1_2022.pdf
ChemistryToday C&G Therapy Article by Brian Mullan Head of Development & Innovation Read More »
"*" indicates required fields
